GS Biotech key facts
as of Oct 2026- Developer of furans bio-based materials designed to reduce carbon emissions.
- GS Biotech is valued at approximately $417.3M as of Oct 2026 (last reported valuation).
- It has raised $56.2M; the latest was Early Stage VC ($27.6M) in Feb 2025.
- Notable investors include Plug and Play Tech Center, Puhua Capital, Legend Capital, 5Y Capital, Eastern Bell Venture Capital — 15 tracked in total.
- Status: Privately Held (backing).
GS Biotech's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch GS Biotech: the Monday email on marks, rounds and moves
GS Biotech funding rounds
No funding rounds for GS Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs GS Biotech
15+Membership and data by Private Market View
GS Biotech valuation
GS Biotech's last reported valuation was $417 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
GS Biotech investors
15 investors are on record for GS Biotech, including Plug and Play Tech Center, Puhua Capital, Legend Capital and 5Y Capital.
About GS Biotech
Developer of furans bio-based materials designed to reduce carbon emissions. The company engages in biomass catalytic conversion and furan-based material design and development, contributing to the carbon peak and carbon neutrality targets.
- Sector
- Materials and Resources
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- guoshengtech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.